Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,100 | -49,375 | -24,303 | -96,015 | -75,679 |
| Depreciation Amortization | -822 | -19 | -213 | 173 | 1,111 |
| Accounts payable and accrued liabilities | 1,390 | 472 | -596 | -764 | -898 |
| Other Working Capital | 721 | -2,115 | -2,854 | -8,868 | -6,357 |
| Other Operating Activity | 10,444 | 4,378 | 2,774 | 11,294 | 8,466 |
| Operating Cash Flow | $-70,367 | $-46,659 | $-25,192 | $-94,180 | $-73,357 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,208 | -43,236 | -38,346 | 11,204 | -34,182 |
| PPE Investments | -450 | -435 | -149 | -1,515 | -1,425 |
| Other Investing Activity | 5 | 5 | 5 | 0 | 0 |
| Investing Cash Flow | $-54,653 | $-43,666 | $-38,490 | $9,689 | $-35,607 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -345 | -225 | N/A | N/A | N/A |
| Common Stock Issued | 120,808 | 117,432 | 112,066 | 2,974 | 2,539 |
| Other Financing Activity | -4,966 | -4,966 | -4,825 | 148 | 78 |
| Financing Cash Flow | $115,497 | $112,241 | $107,241 | $3,122 | $2,617 |
| Beginning Cash Position | 75,848 | 75,848 | 75,848 | 157,217 | 157,217 |
| End Cash Position | 66,325 | 97,764 | 119,407 | 75,848 | 50,870 |
| Net Cash Flow | $-9,523 | $21,916 | $43,559 | $-81,369 | $-106,347 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,367 | -46,659 | -25,192 | -94,180 | -73,357 |
| Capital Expenditure | -450 | -435 | -149 | -1,515 | -1,425 |
| Free Cash Flow | -70,817 | -47,094 | -25,341 | -95,695 | -74,782 |